A European Medicines Agency (EMA) committee said on Friday it has started a review of decongestant medicines for cold and flu that contain the ingredient pseudoephedrine following safety concerns.
The EMA said the review was due to reports of conditions affecting blood vessels in the brain in some patients who took pseudoephedrine-containing medicines.
Pseudoephedrine is a drug that is used alone or in combination with other medicines to treat a blocked nose due to cold, flu or allergy.
Makers of pseudoephedrine-containing drugs include Reckitt Benckiser, McNeil Products Ltd and Organon & Co.
(Reporting by Sriparna Roy in Bengaluru; editing by Shounak Dasgupta)
Topics Europe
Was this article valuable?
Here are more articles you may enjoy.
Guidance and Insurance Implications for the CDK Global Cyberattack 
House Collapses Into Flood-Swollen River Near Minnesota Dam Amid Storms 
German Insurtech Wefox to Replace CEO After Board Rejects Mubadala Sales Plan 
Big ‘I’ Report: Independent Agency Channel Placed 62% of Premiums in 2023 
